[HTML][HTML] Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC)

P Viveiros, A Riaz, RJ Lewandowski, D Mahalingam - Cancers, 2019 - mdpi.com
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …

[HTML][HTML] A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with 68Ga, 44Sc, 177Lu and 161Tb

Z Talip, C Favaretto, S Geistlich, NP Meulen - Molecules, 2020 - mdpi.com
The production of novel radionuclides is the first step towards the development of new
effective radiopharmaceuticals, and the quality thereof directly affects the preclinical and …

Efficacy and safety of radiotherapy for primary liver cancer

W Chen, CL Chiang, LA Dawson - Chinese Clinical Oncology, 2020 - hub.hku.hk
Primary liver cancer includes hepatocellular carcinoma (HCC, 75–85%) and intrahepatic
cholangiocarcinoma (10–15%). The vast majority of patients with primary HCC are not …

Holmium-166 radioembolization in hepatocellular carcinoma: feasibility and safety of a new treatment option in clinical practice

CG Radosa, JC Radosa, S Grosche-Schlee… - CardioVascular and …, 2019 - Springer
Purpose To investigate clinical feasibility, technical success and toxicity of 166 Ho-
radioembolization (166 Ho-RE) as new approach for treatment of hepatocellular carcinomas …

[HTML][HTML] Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma

N Van Thai, NT Thinh, TD Ky, MH Bang, DT Giang… - BMC …, 2021 - Springer
Background This retrospective analysis was undertaken to evaluate the efficiency of SIRT
with Y-90 microspheres and determined prognostic factors affecting patients with …

[HTML][HTML] Selecting the appropriate downstaging and bridging therapies for hepatocellular carcinoma: what is the role of transarterial radioembolization? a pooled …

V Lopez-Lopez, K Miura, C Kuemmerli, A Capel… - Cancers, 2023 - mdpi.com
Simple Summary The usefulness of transarterial radioembolization (TARE) as a treatment
has been endorsed by different authors and recommended by a multidisciplinary working …

HCC: Transarterial therapies—What the interventional radiologist can offer

TJ Vogl, T Gruber-Rouh - Digestive Diseases and Sciences, 2019 - Springer
With the increasing incidence of hepatocellular carcinoma (HCC) and its high mortality rates,
effective treatment options are of urgent need, preferably in a multidisciplinary setting. In the …

[HTML][HTML] Clinical consensus statement: selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia

DM Liu, TWT Leung, PKH Chow, DCE Ng… - International Journal of …, 2022 - Elsevier
Background Hepatocellular carcinoma (HCC) is subject to different management
approaches and guidelines according to Eastern and Western therapeutic algorithms. Use …

Same-day yttrium-90 radioembolization: feasibility with resin microspheres

MD Li, KF Chu, A DePietro, V Wu… - Journal of Vascular and …, 2019 - Elsevier
Purpose To evaluate the feasibility of a same-day yttrium-90 (90 Y) radioembolization
protocol with resin microspheres (including pretreatment angiography, lung shunt fraction …

Cost-effectiveness analysis of selective internal radiotherapy with yttrium-90 versus sorafenib in locally advanced hepatocellular carcinoma

KE Marqueen, E Kim, C Ang, M Mazumdar… - JCO oncology …, 2021 - ascopubs.org
PURPOSE: The recent sorafenib versus radioembolization in advanced hepatocellular
carcinoma (SARAH) and selective internal radiation therapy versus sorafenib in locally …